Quantum-Si (QSI)
1.29
-0.09 (-6.52%)
At close: Mar 03, 2025, 3:59 PM
1.25
-3.47%
After-hours: Mar 03, 2025, 07:34 PM EST
Company Description
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing.
It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing.
The company was incorporated in 2013 is based in Guilford, Connecticut.
Quantum-Si
| Country | United States |
| IPO Date | Nov 13, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 159 |
| CEO | Jeffrey Alan Hawkins |
Contact Details
Address: 530 Old Whitfield Street Guilford, Connecticut United States | |
| Website | https://www.quantum-si.com |
Stock Details
| Ticker Symbol | QSI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001816431 |
| CUSIP Number | 74765K105 |
| ISIN Number | US74765K1051 |
| Employer ID | 85-1388175 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey Alan Hawkins | President, Chief Executive Officer & Director |
| Jeffry R. Keyes CPA | Chief Financial Officer & Treasurer |
| Todd Rearick | Chief Technology Officer |
| Dr. Christian Lapointe J.D., Ph.D. | General Counsel & Corporate Secretary |
| Dr. Jonathan M. Rothberg Ph.D. | Founder & Executive Director |
| Johan Denecke | Senior Vice President of Operations |
| John S. Vieceli | Chief Product Officer |
| Katherine Atkinson | Senior Vice President of Demand Generation & Corporate Brand |
| Todd C. Bennett | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 04, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Jan 10, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Jan 06, 2025 | 8-K | Current Report |
| Jan 06, 2025 | 424B5 | Filing |
| Dec 31, 2024 | SCHEDULE 13D/A | [Amend] Filing |
| Dec 31, 2024 | 4 | Filing |
| Dec 26, 2024 | 4 | Filing |
| Dec 11, 2024 | 8-K | Current Report |